AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2009
Sep 1, 2009
30339_dirs_2009-09-01_94375dce-a570-4384-ba34-de0bfdf46374.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-08-31
Reporting Person: ELLERS STEVEN A (COO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-08-31 | Common Stock | M | 10000 | $13.0157 | Acquired | 125210.302 | Direct |
| 2009-08-31 | Common Stock | S | 10000 | $39.886 | Disposed | 115210.302 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-08-31 | Stock Option (Right to Buy) | $13.0157 | M | 10000 | Disposed | 2005-03-25 | Common Stock (10000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3415.0261 | Indirect |
| Common Stock | 33121.4471 | Indirect |
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27